logo
Plus   Neg
Share
Email

Illumina Tanks 13% As Q2 Results Miss Estimates

Shares of Illumina Inc. (ILMN) slipped more than 13% in after-hours trading after the biotech company reported a second-quarter results that fell short of Wall Street expectations, hurt largely pandemic-related disruptions.

Second-quarter net income was $47 million or $0.32 per share, compared to $296 million or $1.99 per share last year.

Adjusted income for the quarter was $92 million or $0.62 per share, compared to $200 million or $1.35 per share last year.

Revenues for the quarter dropped 25% to $633 million from $838 million last year.

Analysts polled by Thomson Reuters expected earnings of $0.67 per share on revenues of $679.56 million for the quarter.

"As expected, the second quarter was significantly impacted by pandemic-related disruption in our customers' operations and was particularly challenging for many of our research customers who remain closed or operating at limited scale," said Francis deSouza, President and CEO. "It is clear that the role of genomics in infectious disease will continue to grow through and beyond this pandemic."

ILMN closed Thursday's trading at $399.33, down $1.41 or 0.35%, on the Nasdaq. The stock further dropped $52.45 or 13.13% in the after-hour trading.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration (FDA) has gone ahead with the approval of antiviral drug remdesivir as first treatment for COVID-19, notwithstanding last week's findings by the World Health Organization (WHO) that the drug is not effective for COVID-19 treatment. Thursday, Gilead Sciences announced that the FDA approved remdesivir, sold under the brand name Veklury. Integrated payments firm American Express Co. (AXP) reported Friday that net income for the third quarter declined to $1.1 billion or $1.30 per share from $1.8 billion or $2.08 per share in the prior-year quarter. Consolidated total revenues, net of interest expense, also decreased 20 percent to $8.8... The Federal Trade Commission or FTC has launched a new fraud reporting platform, using which, consumers can easily report fraud and all other consumer issues directly to the regulator. In a statement, the FTC said its new website, ReportFraud.ftc.gov, will provide a streamlined and user-friendly way to submit reports about scams, frauds, and bad business practices.
Follow RTT